Baidu
map

肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

CLIN CANCER RES：KPC1泛素连接酶影响黑色素瘤NK-κB通路

2017-08-28 MedSci MedSci原创

黑色素瘤KPC1NF-κB
关注

NF-κB通路异常活动会诱导产生侵袭性更强的皮肤黑色素瘤亚型。研究黑色素瘤NF-κB通路的机制有助于选择针对该通路的靶向分子。KPC1，E3泛素连接酶，是NF-κB通路的调剂因素。CLIN CANCER RES近期发表了一篇文章，研究调节KPC1表达的机制以及其对黑色素瘤的临床影响。

NF-κB通路异常活动会诱导产生侵袭性更强的皮肤黑色素瘤亚型。研究黑色素瘤NF-κB通路的机制有助于选择针对该通路的靶向分子。KPC1，E3泛素连接酶，是NF-κB通路的调剂因素。CLIN CANCER RES近期发表了一篇文章，研究调节KPC1表达的机制以及其对黑色素瘤的临床影响。

作者通过分析黑色素瘤组织标本评估KPC1表达及遗传学调控的临床意义。并使用黑色素瘤细胞系研究KPC1和NK-κB之间的功能联系，KPC1遗传学调控，包括DNA甲基化和miRNA表达。研究结果表明，KPC1通过促进NK-κB1 p105 到p50 抑制黑色素瘤增殖。同时，与早期黑色素瘤相比，Ⅳ期黑色素瘤的KPC1表达显着下调。KPC1低表达与Ⅳ期黑色素瘤不良预后显着相关。此外，受DNA甲基化控制的高miR-155-5p表达，与KPC1下调显着相关。

文章最后认为，KPC1遗传调控与NF-κB通路活化，促进黑色素瘤进展相关。这些研究结果表明KPC1有作为潜在治疗靶点的可能。

原始出处：
Yuuki lida,Aaron Ciechanover,et al.Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.CLIN CANCER RES.August 2017 doi:10.1158/1078-0432.CCR-17-0146

本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2018-05-22 sunylz

    #色素#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2018-03-17 lishiwen

    #连接酶#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 lietome15

    好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 cqlidoudou

    #黑色素#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 cqlidoudou

    #黑色素#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1680436, encodeId=97581680436c7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Tue May 22 14:24:00 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023411, encodeId=deed202341101, content=<a href='/topic/show?id=16639453872' target=_blank style='color:#2F92EE;'>#连接酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94538, encryptionId=16639453872, topicName=连接酶)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Mar 17 21:24:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238579, encodeId=0e042385e9a7, content=好文.值得点赞.更值得收藏!慢慢领会学习的.给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Wed Aug 30 08:18:45 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558831, encodeId=acf51558831a6, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564840, encodeId=57541564840d7, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Wed Aug 30 07:24:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=238475, encodeId=049b2384e555, content=学习过了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好！, createdTime=Wed Aug 30 00:41:01 CST 2017, time=2017-08-30, status=1, ipAttribution=)]
    2017-08-30 明天会更好！

    学习过了.谢谢分享!

    0

相关资讯

J Am Acad Dermatol：磷酸二酯酶5抑制剂与黑色素瘤进展的风险增加相关（Meta分析）

5型磷酸二酯酶抑制剂是一种抑制磷酸二酯酶活性的药物。选择性的磷酸二酯酶5抑制剂在男性勃起功能障碍等疾病中，具有广泛的应用前景。但是，来自美国印第安纳州的研究人员探讨了5型磷酸二酯酶抑制剂与黑色素瘤风险之间的相关性，并将结果发表在7月的J Am Acad Dermatol上，研究摘要如下：背景：5型磷酸二酯酶（PDE5）抑制剂和黑色素瘤的风险之间的相关性是有争议的。目的：旨在量化PDE5抑制剂的使用

J Am Acad Dermatol：黑色素瘤局部广泛切除术后切缘阳性或可疑阳性的危险因素有哪些？

对所有恶性肿瘤的手术切除边缘已有了反复的讨论。皮肤黑色素瘤术后的切缘阳性的风险多大？危险因素有哪些？7月发表在J Am Acad Dermatol上的一项研究对其进行了探讨，研究的主要内容如下：背景：局部广泛切除术（WLE）后的切缘阳性或可疑阳性会恶化皮肤黑色素瘤外科治疗后的结局。目的：旨在识别皮肤黑色素瘤患者行局部广泛切除术后，切缘阳性或可疑阳性的频率和风险因素。方法：这是一项回顾性、单中心，包

J Am Acad Dermatol：PDL1表达与黑色素瘤的侵袭性和进展相关

程序性死亡配体1（programmed death ligand 1，PDL1）、CD8和叉头样转录因子3（FoxP3）的表达对结缔组织增生性恶性黑色素瘤的预后作用仍未阐明。因此，来自美国的研究人员对其进行了探讨，并将研究结果发表在7月份的J Am Acad Dermatol上，研究的主要内容如下：研究人员在66名结缔组织增生性恶性黑色素瘤患者中探讨了PDL1、p53和Ki-67的表达与CD8 +

JCO ：Nivolumab+Ipilimumab联合治疗黑色素瘤的疗效和安全性研究

Novilumab+ipilimumab联合治疗晚期黑色素瘤的患者中，大约40%的患者由于不良事件(AEs)而停止治疗。近日，在医学权威杂志JCO上面发表了一篇研究文章，研究人员采用回顾性分析方法，评估了Nivolumab+Ipilimumab联合治疗的黑色素瘤患者因不良事件(AEs)而停止治疗的疗效和安全性。

Cell:免疫疗法大牛James Allison全新：PD-1抗体与CTLA-4抗体原来如此不同

MD安德森癌症中心的James P. Allison教授是癌症免疫疗法的先驱之一，也被称“CTLA-4抗体Yervoy之父”。去年，他还荣获了有着诺奖风向标之称的汤森路透“引文桂冠奖”。近日，他带领的研究小组在Cell杂志上发表了一项新成果，揭开了CTLA-4抗体和PD-1抗体这两类癌症免疫疗法不同的细胞机制。

治疗黑色素瘤靶向药获批进入中国，专家提醒：不要随便点痣

治疗“癌中之王”黑色素瘤的靶向药日前获批进入中国，并被纳入《中国黑色素瘤诊治指南(2017版)》，标志着国内黑色素瘤治疗迈入靶向时代。

Baidu
map
Baidu
map
Baidu
map